Preparing for the future.
Cox
S
S
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000081:Acetamides / Q000627:therapeutic use; D000098:Acetophenones / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D003521:Cyclopropanes; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage; D019888:Nelfinavir; D010078:Oxazines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000008:administration & dosage; D014498:Uracil / Q000627:therapeutic use / Q000031:analogs & derivatives
D000081:Acetamides; D000098:Acetophenones; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D013451:Sulfonic Acids; C080073:loviride; D014498:Uracil; D019888:Nelfinavir; C098320:efavirenz; C083858:emivirine